FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Akorn Rifampin Capsules Recall

Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operati…

Akorn, Inc. · Gurnee, IL

Risk level
Class II
Reported by FDA
Oct 5, 2022
Recall ID
D-1547-2022
Check your lot numberHow we source this data

Summary

Akorn recalled Rifampin Capsules starting Sep 21, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1547-2022 on Oct 5, 2022. Reason: Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP). Status: Ongoing.

Why it was recalled

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

Product description

Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031, NDC 61748-015-30

Lot numbers, UPCs & expiration codes

Lot#: 3192818, Exp 10/31/2022; 3199700, Exp 03/31/2023; 3203853, Exp 02/29/2024

Where it was sold

USA Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1547-2022
Classification
Class II
Status
Ongoing
Recall initiated
Sep 21, 2022
FDA report date
Oct 5, 2022
Quantity
18,145 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-1547-2022, exactly as published.

Show all FDA fields
City
Gurnee
State
IL
Status
Ongoing
Country
United States
Event ID
90880
Address
5605 Centerpoint Ct Ste A
Code information
Lot#: 3192818, Exp 10/31/2022; 3199700, Exp 03/31/2023; 3203853, Exp 02/29/2024
Postal code
60031-5278
Report date
Oct 5, 2022
Product type
Drugs
Recall number
D-1547-2022
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
18,145 bottles
Reason for recall
Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031, NDC 61748-015-30
Distribution pattern
USA Nationwide and Puerto Rico
Recall initiation date
Sep 21, 2022
Initial firm notification
Letter
Center classification date
Sep 28, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1547-2022, published Oct 5, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls